Back to Journals » Journal of Blood Medicine » Volume 11

In vitro Fertilization Procedures with Embryo Transfer and Their Association with Thrombophilia, Thrombosis and Early Antithrombotic Treatments

Authors Di Micco P, Russo V, Mastroiacovo D, Bosevski M, Lodigiani C

Received 9 February 2020

Accepted for publication 28 May 2020

Published 11 June 2020 Volume 2020:11 Pages 185—190


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Martin H. Bluth

Pierpaolo Di Micco,1 Vincenzo Russo,2 Daniela Mastroiacovo,3 Marijan Bosevski,4 Corrado Lodigiani5

1Department of Internal Medicine, Fatebenefratelli Hospital of Naples, Naples, Italy; 2Chair of Cardiology, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli” Monaldi Hospital, Naples 80131, Italy; 3Angiology Unit, Ospedale SS. Filippo e Nicola, Avezzano, Italy; 4University Cardiology Clinic, Faculty of Medicine, Skopje, N.Macedonia; 5Thrombosis and Hemorrhagic Center, Humanitas Research Hospital and Humanitas University, Rozzano, Italy

Correspondence: Pierpaolo Di Micco
Department of Internal Medicine, Fatebenefratelli Hospital of Naples, Naples, Italy

Abstract: In vitro fertilization (IVF) procedures have been frequently associated with antithrombotic treatments, in particular, to aspirin or low-molecular-weight heparin (LMWH). The rationale of this treatment is based on the increase of thrombotic risk occurring in this clinical context. Indeed, both prothrombotic changes of coagulation parameters specifically related to IVF procedures as well as the presence of potential thrombophilic alterations may concur to increase the risk in these women. Furthermore, the presence of thrombophilia has been suggested as a potential cause of recurrent IVF failures. Therefore, antithrombotic treatments have been historically planned to prevent thrombotic disorders during pharmacological ovarian stimulation and/or to increase a successful rate of pregnancy and live births after IVF with embryo transfer. However, up to date, the role of inherited and|or acquired thrombophilia is still debated as well as a univocal therapeutic approach is lacking in women with infertility. The administration of antithrombotic drugs differs in several studies and even the dosages of aspirin and|or low-molecular-weight heparin are different. This review focuses on underlining current evidence on the role of thrombophilia and thromboprophylaxis in women selected for IVF with embryo transfer.

Keywords: sterility, in vitro fertilization, thrombophilia, low-molecular-weight heparin, aspirin, ovarian hyper-stimulation syndrome

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]